Press Releases
-
6 Nov, 2024Spago Nanomedical interim report January-September 2024
-
21 Oct, 2024Nomination committee appointed for Spago Nanomedical’s Annual General Meeting 2025
-
1 Oct, 2024Spago Nanomedical in new phase with full focus on the Tumorad program
-
27 Aug, 2024Spago Nanomedical’s Phase I/IIa study Tumorad-01 continues following successful treatment completion of first patient group
-
21 Aug, 2024Spago Nanomedical interim report January-June 2024